ZYME Overview
Upcoming Projects (ZYME)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ZYME)
-
Discussing the Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024
Tickers: ZYME, JAZZ, BGNE
Executed On: Oct 11, 2024 at 04:30 PM EDT -
Discussing Zymeworks’ Zanidatamab (ZW25) in HER2-positive biliary tract cancers (BTCs) with topline data from the HERIZON-BTC-01 Trial
Ticker: ZYME
Executed On: Jan 23, 2023 at 07:00 PM EST
Expired Projects (ZYME)
-
Zanidatamab: A New Horizon in Treating HER2-Positive/HR-Positive Metastatic Breast Cancer
Ticker: ZYME
Execute By: Jan 31, 2024
Upcoming & Overdue Catalysts (ZYME)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (ZYME)
Strategic Initiatives (ZYME)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
